ArticleHeliyon2025
Camel milk and D-allulose synergistically improved camel dairy flavor and alleviated insulin resistance of human HepG2 cells.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improvement of Quality of Sour Camel Milk by Extract ofFoods (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Camel milk is a dairy product widely consumed in desert and semi-arid areas, with high nutritional value and potential for auxiliary medical treatment. It has unique efficacy and a gamey taste, and exploring its functional factors and making camel milk more easily accepted by the public has become a research hotspot. This study mainly investigated the protein components in camel milk that may play a role in alleviating insulin resistance by observing the cell activity, glucose consumption, and morphological changes of the treatment group. Further research was conducted on the potential synergistic hypoglycemic effect of camel milk and D-allulose, and a formula was ultimately determined to enhance the flavor of camel milk through a series of sensory evaluation experiments. The optimal concentration for the treatment of insulin resistance (IR) was identified as 4 mg/mL of CWP4 combined with 1 mg/mL of D-allulose for a period of 12 h. The addition of D-allulose at a ratio of 1:36 in camel milk has been observed reduce the odoriferous properties of the camel milk, while simultaneously retaining the majority of other desirable flavors. This research helps to concentrate the functional protein factors in camel milk, promote the intensive processing of camel milk, and develop new camel milk health products. These products may help patients with diabetes stabilize their blood sugar levels in daily life, thus enriching their diet, and may expand the market of camel milk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.